Strategic partnerships Medicines Discovery Catapult positions itself as a globally integrated accelerator with investor-grade data and regulatory-aligned workflows, offering a clear opportunity to partner with biotech and pharma developers seeking de-risked translational programs and accelerated clinical momentum.

Full-stack capabilities MDC provides end-to-end capabilities in radiopharmaceuticals, translational imaging, in vitro biology, biomarkers, and R&D consultancy, creating cross-selling opportunities across organizations needing integrated preclinical to early clinical support.

Global access With international collaborations across 15 countries and a diverse 140+ expert team, MDC can serve multinational programs and help clients navigate regulatory and translational challenges across markets.

Imaging and biomarkers Strong emphasis on precision imaging biomarkers and dosimetry, offering a differentiated path for customer programs requiring target engagement validation and patient stratification data to de-risk early development.

Leadership and growth Recent leadership appointments and strategic hires signal a growth trajectory and expanded commercial focus, presenting an opening for proactive outreach to secure senior-level partnerships and collaborations with biotech and pharma accounts.